NO156373C - AnalogifremgangsmŸte for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater. - Google Patents

AnalogifremgangsmŸte for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.

Info

Publication number
NO156373C
NO156373C NO820253A NO820253A NO156373C NO 156373 C NO156373 C NO 156373C NO 820253 A NO820253 A NO 820253A NO 820253 A NO820253 A NO 820253A NO 156373 C NO156373 C NO 156373C
Authority
NO
Norway
Prior art keywords
furo
preparation
pyridine derivatives
therapeutic active
analogical procedure
Prior art date
Application number
NO820253A
Other languages
English (en)
Norwegian (no)
Other versions
NO156373B (no
NO820253L (no
Inventor
Andre Esanu
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of NO820253L publication Critical patent/NO820253L/no
Publication of NO156373B publication Critical patent/NO156373B/no
Publication of NO156373C publication Critical patent/NO156373C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
NO820253A 1981-02-10 1982-01-28 AnalogifremgangsmŸte for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater. NO156373C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8104072 1981-02-10

Publications (3)

Publication Number Publication Date
NO820253L NO820253L (no) 1982-08-11
NO156373B NO156373B (no) 1987-06-01
NO156373C true NO156373C (no) 1987-09-09

Family

ID=10519587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820253A NO156373C (no) 1981-02-10 1982-01-28 AnalogifremgangsmŸte for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.

Country Status (34)

Country Link
US (1) US4383998A (zh)
JP (1) JPS57150688A (zh)
KR (1) KR870000206B1 (zh)
AR (1) AR230284A1 (zh)
AU (1) AU545876B2 (zh)
BE (1) BE891797A (zh)
CA (1) CA1175837A (zh)
CH (1) CH649554A5 (zh)
DE (1) DE3204596A1 (zh)
DK (1) DK157551C (zh)
DZ (1) DZ376A1 (zh)
ES (1) ES509449A0 (zh)
FI (1) FI75347C (zh)
FR (2) FR2499406A1 (zh)
GB (1) GB2092586B (zh)
GR (1) GR75905B (zh)
HK (1) HK22485A (zh)
HU (1) HU185088B (zh)
IE (1) IE52376B1 (zh)
IL (1) IL64759A (zh)
IN (1) IN156817B (zh)
IT (1) IT1157252B (zh)
LU (1) LU83886A1 (zh)
MA (1) MA19378A1 (zh)
MX (1) MX6983E (zh)
NL (1) NL186697C (zh)
NO (1) NO156373C (zh)
NZ (1) NZ199528A (zh)
OA (1) OA07003A (zh)
PT (1) PT74408B (zh)
SE (1) SE456994B (zh)
SG (1) SG85384G (zh)
YU (1) YU44000B (zh)
ZA (1) ZA82158B (zh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
IN160104B (zh) * 1983-04-05 1987-06-27 Scras
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
GB0221494D0 (en) * 2002-09-16 2002-10-23 Generics Uk Ltd Novel processes for the preparation of 1.3-dihydro-6-methylfuro (3,4-c) pyndin derivatives
HUP0300990A2 (hu) * 2003-04-15 2005-05-30 SynoSens Kutató és Fejlesztő Kft. Szinergista gyógyszer-kombináció a diabetesz megelőzésére vagy kezelésére
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
CA2532807A1 (en) * 2003-07-17 2005-02-03 Cotherix, Inc. Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
EP1804795A4 (en) * 2004-09-22 2007-11-07 Cornett Glen ENANTIOMERIC COMPOSITIONS OF CICLETANINE, ALONE OR COMBINED WITH OTHER AGENTS, USED FOR THERAPEUTIC PURPOSES
US20060153934A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and magnesium
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
WO2008085872A1 (en) * 2007-01-03 2008-07-17 Cornett Glenn V Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
US8214941B2 (en) 2008-10-02 2012-07-10 Kohler Co. Slip-fit clamping system for mounting a fitting on a wall
WO2011043914A1 (en) * 2009-10-09 2011-04-14 Merck Sharp & Dohme Corp. Diuretics
WO2011053519A1 (en) * 2009-10-29 2011-05-05 Merck Sharp & Dohme Corp. Diuretics
WO2015103445A1 (en) * 2013-12-31 2015-07-09 Rockey Don C Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use

Also Published As

Publication number Publication date
FI75347C (fi) 1988-06-09
FR2499406A1 (fr) 1982-08-13
FI75347B (fi) 1988-02-29
CH649554A5 (fr) 1985-05-31
FR2499574A1 (fr) 1982-08-13
AU8029482A (en) 1982-08-19
LU83886A1 (fr) 1982-06-30
IN156817B (zh) 1985-11-09
IL64759A0 (en) 1982-03-31
JPS57150688A (en) 1982-09-17
IT1157252B (it) 1987-02-11
GR75905B (zh) 1984-08-02
DK54382A (da) 1982-08-11
AU545876B2 (en) 1985-08-01
SE456994B (sv) 1988-11-21
KR830009106A (ko) 1983-12-17
PT74408B (en) 1983-07-07
DK157551C (da) 1990-06-11
IE820288L (en) 1982-08-10
DE3204596A1 (de) 1982-09-09
SE8200744L (sv) 1982-08-11
NO156373B (no) 1987-06-01
IE52376B1 (en) 1987-09-30
NZ199528A (en) 1984-02-03
DE3204596C2 (zh) 1991-07-04
ZA82158B (en) 1982-11-24
IL64759A (en) 1985-09-29
IT8219502A0 (it) 1982-02-08
SG85384G (en) 1985-06-07
NL8200180A (nl) 1982-09-01
GB2092586B (en) 1984-09-26
DZ376A1 (fr) 2004-09-13
ES8302714A1 (es) 1983-01-16
KR870000206B1 (ko) 1987-02-16
CA1175837A (en) 1984-10-09
GB2092586A (en) 1982-08-18
MA19378A1 (fr) 1982-10-01
YU25382A (en) 1984-08-31
AR230284A1 (es) 1984-03-01
FR2499406B1 (zh) 1984-03-30
YU44000B (en) 1990-02-28
US4383998A (en) 1983-05-17
OA07003A (fr) 1983-08-31
HK22485A (en) 1985-03-29
NL186697C (nl) 1991-02-01
HU185088B (en) 1984-11-28
JPH0261477B2 (zh) 1990-12-20
BE891797A (fr) 1982-04-30
ES509449A0 (es) 1983-01-16
NO820253L (no) 1982-08-11
MX6983E (es) 1987-01-19
FI820353L (fi) 1982-08-11
FR2499574B1 (zh) 1984-03-30
DK157551B (da) 1990-01-22
NL186697B (nl) 1990-09-03
PT74408A (en) 1982-03-01

Similar Documents

Publication Publication Date Title
NO156373C (no) AnalogifremgangsmŸte for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.
NO156785B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO158100C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo (4,5-c)pyridinderivater.
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO853046L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-derivater.
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO162514C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinonderivater.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO160369C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive 1,3-dihydro-6-(1-hydroksy-2-dimetylaminometyl-allyl)-7-hydroksy-furo(3,4-c)-pyridinderivater.
NO821085L (no) Fremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO161802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive furo-(3,4-c)-pyridinderivater.
NO157819C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo (1,2-a)-pyridin-2-yl-karbostyrilforbindelser.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO155665C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater.
NO155771C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminopropanolderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO165104C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1, 1-disubstituerte cyklopropanderivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JANUARY 2002